Health Care

Drugmaker Mylan on Thursday used a provision of Dutch law to put up a barrier that makes it harder for larger rival Teva Pharmaceutical Industries to buy the company.

Drug maker Roche Holding AG says its first-half profit was weighed down by the surging Swiss franc and one-time effects, while solid sales of cancer treatments helped push revenue higher.

Pfizer is expanding its research on vaccines to eventually cover the entire lifespan, from shots for pregnant women to protect babies from the moment of birth to vaccines for senior citizens with waning immune systems.

A federal appeals court has ruled that Novartis can begin selling its lower-cost copy of an Amgen Inc. drug in September, rejecting a bid to further delay the launch of the knock-off biotech medication.

Drugmaker Horizon Pharma PLC is boosting its offer for Depomed to $33 per share.

Ohio has licensed a clinic that plans to start offering surgical abortions while other abortion providers wrangle with the state over backup-care requirements that could make it more difficult for them to continue, state records show.

Cancer drug maker Celgene says it will buy drug developer Receptos for $7.32 billion cash, gaining a drug Receptos is studying as a treatment for multiple sclerosis and ulcerative colitis.

Depomed has adopted a "poison pill" plan less than a week after Horizon Pharma went hostile with a $2.1 billion takeover bid.

Federal health regulators are bolstering warning labels on popular pain relievers like Advil and Aleve, adding new information about the risks of heart attack and stroke.

Walgreens Boots Alliance Inc. is naming Stefano Pessina CEO, making permanent a role the executive has filled since the largest drugstore chains in the United States and Great Britain closed their combination at the end of last year.

South Carolina's highest court has further reduced the penalty against a Johnson & Johnson subsidiary accused of deceptive drug marketing.

The group formed by Gov. Gina Raimondo to transform the Medicaid system recommended paying health care providers for the quality of their services in its final report, which was released Wednesday.

Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE Humana Inc. (HUM), up $1.46 to $188.96 The health insurer provided a lower-than-expected second-quarter profit outlook as it moves ahead with its buyout of Aetna Inc.

Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE MBIA Inc., down $1.95 to $6.37 The financial guarantee insurance company's shares fell as Puerto Rico's governor warns that the island can't pay its $72 billion public debt.

Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE Lennar Corp., up $2.06 cents to $51.06 The homebuilder reported better-than-expected fiscal second-quarter profit and revenue on a boost in home sales and prices.

Bristol-Myers Squibb Co. will expand its presence in research centers in Cambridge, Massachusetts, and San Francisco, as it cuts jobs in Connecticut, the biopharmaceutical company announced Thursday.

Orthopedic device makers Zimmer Holdings and Biomet say they've completed their $13.35 billion cash-and-stock combination.

The heir of the Samsung business group made a deep bow in apology as criticism mounts on a Samsung hospital for its role in spreading the Middle East respiratory syndrome.